General Catalyst Group Management, LLC

Holdings as of 2026-06-30, filed 2026-08-17

This is history, not a current position. These holdings describe 2026-06-30, and the report became public 48 days later. The portfolio has changed since.

Aggregates

computed from the positions below
Positions reported
14
Value reported by manager
$188.5M
Sum of our stored positions
$188.5M
should match the line above
Disclosure lag
48 d
quarter end to filing
Top 5 concentration
93.1%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls

Positions

14 largest shown
IssuerClassValueSharesTypeCUSIP
ArriVent BioPharma, Inc.COM$51.9M1,494,78604272N102
Parabilis Medicines, Inc.COM$43.8M1,600,937698955101
Maplebear, Inc.COM$33.7M710,711565394103
Maze Therapeutics, Inc.COM$30.9M1,035,910578784100
Odyssey Therapeutics, Inc.COMMON STOCK$15.2M810,27267613T104
Eikon Therapeutics, Inc.COM$4M305,233282564103
Fractyl Health, Inc.COM$3.9M4,884,18635168W103
Ethos Technologies, Inc.CL A$1.3M74,17929765A101
Coupang Inc.CL A$949.7K54,67722266T109
Amazon.com Inc.COM$925.2K3,882023135106
Meta Platforms Inc.CL A$743.5K1,32030303M102
Doordash Inc.CL A$525.9K2,85025809K105
Carvana CoCL A$425.5K6,465146869102
Figma, Inc.CLASS A COM STK$268.5K14,845316841105
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.

Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-17